{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=David+Linden&min-answer.dateOfAnswer=2019-05-20&min-answer.questionFirstAnswered.=2019-07-29T15%3A45%3A08.657Z&answer.answeringMember.label=Biography+information+for+Edward+Argar", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=David+Linden&min-answer.dateOfAnswer=2019-05-20&min-answer.questionFirstAnswered.=2019-07-29T15%3A45%3A08.657Z&answer.answeringMember.label=Biography+information+for+Edward+Argar", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=David+Linden&min-answer.dateOfAnswer=2019-05-20&min-answer.questionFirstAnswered.=2019-07-29T15%3A45%3A08.657Z&_metadata=all&answer.answeringMember.label=Biography+information+for+Edward+Argar", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=David+Linden&min-answer.dateOfAnswer=2019-05-20&_page=0&min-answer.questionFirstAnswered.=2019-07-29T15%3A45%3A08.657Z&answer.answeringMember.label=Biography+information+for+Edward+Argar", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=David+Linden&min-answer.dateOfAnswer=2019-05-20&min-answer.questionFirstAnswered.=2019-07-29T15%3A45%3A08.657Z&answer.answeringMember.label=Biography+information+for+Edward+Argar", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=David+Linden&min-answer.dateOfAnswer=2019-05-20&min-answer.questionFirstAnswered.=2019-07-29T15%3A45%3A08.657Z&answer.answeringMember.label=Biography+information+for+Edward+Argar", "items" : [{"_about" : "http://data.parliament.uk/resources/1546812", "AnsweringBody" : [{"_value" : "Ministry of Justice"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1546812/answer", "answerText" : {"_value" : "

The Ministry of Justice has committed to ringfenced funding to increase the number of Independent Sexual and Domestic Violence Advisors (ISVAs/IDVAs) by 300 to over 1000 by 2024/25 - a 43% increase on the number of ISVAs and IDVAs over the next three years. This builds on the funding provided in 20/21 and 21/22 to recruit c700 ISVA and IDVA posts. We are distributing this ringfenced funding to Police and Crime Commissioners (PCCs) to recruit ISVAs and IDVAs in their local areas. Recruitment for the additional 300 posts commenced in May 2022, and we are currently working closely with PCCs to track progress of this recruitment. In addition to this funding, PCCs also have discretion to use core victim support grant funding for additional ISVAs and IDVAs, based on their assessment of local need.<\/p>

The MoJ has information on ISVAs and IDVAs funded from 20/21, which is when the specific ringfenced funding was introduced.<\/p>

In addition, the Department has committed to supporting ISVAs and IDVAs through measures published in the draft Victims Bill. The Bill will introduce a definition of IDVA and ISVA roles, a power for the Secretary of State to issue statutory guidance on these roles, and a duty on agencies and those who work with victims to have due regard to the guidance.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2022-12-08", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-12-08T15:35:59.137Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "54"} , "answeringDeptShortName" : {"_value" : "Justice"} , "answeringDeptSortName" : {"_value" : "Justice"} , "date" : {"_value" : "2022-11-30", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Independent Sexual Violence Advisers"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Justice, how many full-time equivalent independent (a) domestic and (b) sexual violence advisers have been funded by his Department in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4640", "label" : {"_value" : "Biography information for David Linden"} } , "tablingMemberConstituency" : {"_value" : "Glasgow East"} , "tablingMemberPrinted" : [{"_value" : "David Linden"} ], "uin" : "99958"} , {"_about" : "http://data.parliament.uk/resources/1465741", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465741/answer", "answerText" : {"_value" : "

We replied to the hon. Member on 27 May 2022.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2022-06-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-06-07T10:37:15.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-05-25", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Members: Correspondence"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, when he plans to respond to the correspondence of (a) 24 February, (b) 7 April and (c) 28 April 2022 from the hon. Member for Glasgow East, reference DL11390.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4640", "label" : {"_value" : "Biography information for David Linden"} } , "tablingMemberConstituency" : {"_value" : "Glasgow East"} , "tablingMemberPrinted" : [{"_value" : "David Linden"} ], "uin" : "9117"} , {"_about" : "http://data.parliament.uk/resources/1421915", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1421915/answer", "answerText" : {"_value" : "

The Department has no plans to do so, as claims for pension credit are made through the Department for Work and Pensions. The Department\u2019s regulations include some travel to hospital costs.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2022-02-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-02-21T15:28:38.587Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-02-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Hospitals: Pension Credit"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to promote access to support for the cost of travel to hospital by claiming pension credit.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4640", "label" : {"_value" : "Biography information for David Linden"} } , "tablingMemberConstituency" : {"_value" : "Glasgow East"} , "tablingMemberPrinted" : [{"_value" : "David Linden"} ], "uin" : "122800"} , {"_about" : "http://data.parliament.uk/resources/1240926", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1240926/answer", "answerText" : {"_value" : "

The Department commissions research through the National Institute for Health Research (NIHR) and is the largest public funder of health research in the United Kingdom.<\/p>

The NIHR funds a range of research in maternal and neonatal health focussing on the safety of maternity and neonatal services, and the national maternity ambition to halve maternal deaths, stillbirths and neonatal deaths and brain injury by 2025.<\/p>

The NIHR is not currently funding any specific research into neonatal herpes but it welcomes funding applications for research into any aspect of human health, including neonatal herpes. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. In all disease areas, the amount of NIHR funding depends on the volume and quality of scientific activity.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2020-10-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-10-16T07:42:34.503Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-10-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sexually Transmitted Infections: Research"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has allocated funding to the research on neonatal herpes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4640", "label" : {"_value" : "Biography information for David Linden"} } , "tablingMemberConstituency" : {"_value" : "Glasgow East"} , "tablingMemberPrinted" : [{"_value" : "David Linden"} ], "uin" : "99718"} , {"_about" : "http://data.parliament.uk/resources/1149401", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1149401/answer", "answerText" : {"_value" : "

The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a>.<\/p>

We were advised of a temporary supply issue affecting the Elvanse Adult presentation during September. However, this issue is now fully resolved and supplies of all presentations of lisdexamphetamine are currently available in quantities sufficient to meet normal demand.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2019-10-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-21T13:02:33.993Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Lisdexamfetamine"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure there will be an adequate supply of Lisdexamphetamine in the event of the UK\u2019s departure from the EU on 31 October 2019 without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4640", "label" : {"_value" : "Biography information for David Linden"} } , "tablingMemberConstituency" : {"_value" : "Glasgow East"} , "tablingMemberPrinted" : [{"_value" : "David Linden"} ], "uin" : "704"} , {"_about" : "http://data.parliament.uk/resources/1149421", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1149421/answer", "answerText" : {"_value" : "

The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including those for use in the treatment of depression, once we have left the EU.<\/p>

The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:<\/p>

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans<\/a><\/p>

There is no evidence of any supply shortages being related to leaving the European Union. We are aware that one supplier of generic agomelatine 25mg tablets discontinued supplies in July 2019. However, we can confirm that supplies of agomelatine 25mg tablets are currently available from several other suppliers in volumes that are sufficient to meet normal United Kingdom demand. All patients who require agomelatine should be able to obtain a supply from their pharmacy.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2019-10-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-10-23T11:51:13.49Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Agomelatine"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care what steps he is taking to ensure the adequacy of the supply of Agomelatine in the event that the UK leaves the EU on 31 October 2019 without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4640", "label" : {"_value" : "Biography information for David Linden"} } , "tablingMemberConstituency" : {"_value" : "Glasgow East"} , "tablingMemberPrinted" : [{"_value" : "David Linden"} ], "uin" : "712"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }